Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

SODIUM PHENYLACETATE AND SODIUM BENZOATE

SODIUM BENZOATE; SODIUM PHENYLACETATE

Standard Dose
10%;10% (5GM/50ML;5GM/50ML)
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview SODIUM PHENYLACETATE AND SODIUM BENZOATE is listed in Drugs@FDA under application 208521 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BENZOATE; SODIUM PHENYLACETATE Form and strength SOLUTION;INTRAVENOUS - 10%;10% (5GM/50ML;5GM/50ML) Sponsor MAIA PHARMS INC Submission history Latest submission status date: 2023-05-04 00:00:00.

Structured Monograph

Clinical summary

Approval overview SODIUM PHENYLACETATE AND SODIUM BENZOATE is listed in Drugs@FDA under application 208521 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient SODIUM BENZOATE; SODIUM PHENYLACETATE Form and strength SOLUTION;INTRAVENOUS - 10%;10% (5GM/50ML;5GM/50ML) Sponsor MAIA PHARMS INC Submission history Latest submission status date: 2023-05-04 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM BENZOATE; SODIUM PHENYLACETATE) | Drug Monograph | MedicHelpline